iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionWhite Lighthouse Investment Management Inc.
Latest Disclosed Ownership9,275 shares
Latest Disclosed Value $ 1,566,088
White Lighthouse Investment Management Inc. reports 0.04% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - White Lighthouse Investment Management Inc. filed a 13F-HR form disclosing ownership of 9,275 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,566,088 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 9,271 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.04% during the quarter. The current value of the position is $1,215,489 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,275 4 0.04 1,566 0.13 0.2173
2026-02-09 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 9,271 -1,022 -9.93 1,565 5.25 0.2184
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,293 -1,070 -9.42 1,486 3.41 0.2265
2025-07-30 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,363 32 0.28 1,438 -0.83 0.2338
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,331 -808 -6.66 1,449 -9.66 0.2588
2025-02-04 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,139 -380 -3.04 1,605 -11.96 0.2820
2024-10-30 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,519 -49 -0.39 1,823 5.62 0.3270
2024-07-15 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,568 -9 -0.07 1,725 0.00 0.3328
2024-05-07 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,577 -185 -1.45 1,726 -0.46 0.3506
2024-01-23 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,762 350 2.82 1,734 14.24 0.3794
2023-10-18 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,412 -50 -0.40 1,518 -4.11 0.3685
2023-08-07 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,462 60 0.48 1,582 -1.19 0.3777
2023-04-20 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,402 78 0.63 1,602 -1.05 0.4036
2023-01-24 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,324 0 0.00 1,618 12.28 0.4396
2022-10-18 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,324 23 0.19 1,441 -0.41 0.4196
2022-07-20 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,301 3 0.02 1,447 -9.68 0.4140
2022-04-20 2022-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,298 -197 -1.58 1,602 -15.99 0.4075
2022-01-12 2021-12-31 13F Ishares Russell Mid Cap IBB 464287556 12,495 -159 -1.26 1,907 -6.79 0.4752
2021-10-20 2021-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,654 -197 -1.53 2,046 -2.71 0.5490
2021-07-26 2021-06-30 13F iShares Nasdaq Biotechnology In IBB 464287556 12,851 206 1.63 2,103 10.45 0.5762
2021-05-07 2021-03-31 13F iShares Nasdaq Biotechnology In IBB 464287556 12,645 150 1.20 1,904 0.58 0.5826
2021-02-03 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,495 -355 -2.76 1,893 8.79 0.6041
2020-10-15 2020-09-30 13F iShares Nasdaq Biotechnology In Common 464287556 12,850 -1,351 -9.51 1,740 -10.36 0.6024
2020-07-23 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 14,201 27 0.19 1,941 27.11 0.7128
2020-04-07 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 14,174 50 0.35 1,527 -10.28 0.6391
2020-01-24 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 14,124 466 3.41 1,702 25.24 0.6242
2019-11-12 2019-09-30 13F iShares Nasdaq Biotechnology In Common 464287556 13,658 -200 -1.44 1,359 -10.12 0.5469
2019-07-31 2019-06-30 13F iShares Nasdaq Biotechnology In Common 464287556 13,858 -200 -1.42 1,512 -3.82 0.6310
2019-05-08 2019-03-31 13F iShares Nasdaq Biotechnology In Common 464287556 14,058 2,030 16.88 1,572 35.52 0.7217
2019-01-23 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,028 75 0.63 1,160 -20.44 0.6373
2018-10-24 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,953 -1,105 -8.46 1,458 1.67 0.7437
2018-08-09 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 13,058 195 1.52 1,434 4.44 0.7873
2018-04-12 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,863 -410 -3.09 1,373 -3.11 0.7873
2018-01-10 2017-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 13,273 13,273 1,417 0.8138
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.